1. Home
  2. CPSH vs NRXS Comparison

CPSH vs NRXS Comparison

Compare CPSH & NRXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CPS Technologies Corp.

CPSH

CPS Technologies Corp.

HOLD

Current Price

$5.21

Market Cap

68.9M

ML Signal

HOLD

Logo Neuraxis Inc.

NRXS

Neuraxis Inc.

HOLD

Current Price

$7.28

Market Cap

78.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPSH
NRXS
Founded
1984
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Building Materials
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
68.9M
78.9M
IPO Year
1995
2023

Fundamental Metrics

Financial Performance
Metric
CPSH
NRXS
Price
$5.21
$7.28
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$6.00
$13.00
AVG Volume (30 Days)
1.8M
87.4K
Earning Date
05-04-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
113.64
22.13
EPS
N/A
N/A
Revenue
N/A
$3,569,282.00
Revenue This Year
$16.41
$172.91
Revenue Next Year
$20.16
$115.71
P/E Ratio
N/A
N/A
Revenue Growth
N/A
32.89
52 Week Low
$2.11
$2.20
52 Week High
$14.39
$9.33

Technical Indicators

Market Signals
Indicator
CPSH
NRXS
Relative Strength Index (RSI) 42.13 53.64
Support Level $4.61 $6.92
Resistance Level $5.50 $7.79
Average True Range (ATR) 0.68 0.37
MACD -0.21 0.06
Stochastic Oscillator 9.97 81.63

Price Performance

Historical Comparison
CPSH
NRXS

About CPSH CPS Technologies Corp.

CPS Technologies Corp designs, manufactures, and sells high-performance material solutions for customers across various markets, including transportation, energy, automotive, electronics, telecommunications, aerospace, and defense. The company develops and applies proprietary expertise in metal matrix composites (MMCs), which are engineered materials combining metals and ceramics to achieve enhanced performance properties. It also provides baseplates and housings used in radar, satellite and avionics applications. The company provides lids and heat spreaders used with integrated circuits in Internet switches and routers. The majority of the company's revenue is derived from the sale of its products in the United States of America.

About NRXS Neuraxis Inc.

Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).

Share on Social Networks: